Fisher DE - Search Results

1

Biologic Activity of Autologous, Granulocyte-Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines.

Goldberg JM, Fisher DE, Demetri GD, Neuberg D, Allsop SA, Fonseca C, Nakazaki Y, Nemer D, Raut CP, George S, Morgan JA, Wagner AJ, Freeman GJ, Ritz J, Lezcano C, Mihm M, Canning C, Hodi FS, Dranoff G. Goldberg JM, et al. Among authors: fisher de. Clin Cancer Res. 2015 Jul 15;21(14):3178-86. doi: 10.1158/1078-0432.CCR-14-2932. Epub 2015 Mar 24. Clin Cancer Res. 2015. PMID: 25805798 Free PMC article. Clinical Trial.

2

p53 in life and death.

Shimamura A, Fisher DE. Shimamura A, et al. Among authors: fisher de. Clin Cancer Res. 1996 Mar;2(3):435-40. Clin Cancer Res. 1996. PMID: 9816188 Review. No abstract available.

3

Clear cell sarcoma shows immunoreactivity for microphthalmia transcription factor: further evidence for melanocytic differentiation.

Granter SR, Weilbaecher KN, Quigley C, Fletcher CD, Fisher DE. Granter SR, et al. Among authors: fisher de. Mod Pathol. 2001 Jan;14(1):6-9. doi: 10.1038/modpathol.3880249. Mod Pathol. 2001. PMID: 11211309

4

Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers.

Davis IJ, Kim JJ, Ozsolak F, Widlund HR, Rozenblatt-Rosen O, Granter SR, Du J, Fletcher JA, Denny CT, Lessnick SL, Linehan WM, Kung AL, Fisher DE. Davis IJ, et al. Among authors: fisher de. Cancer Cell. 2006 Jun;9(6):473-84. doi: 10.1016/j.ccr.2006.04.021. Cancer Cell. 2006. PMID: 16766266 Free article.

5

Major response to imatinib mesylate in KIT-mutated melanoma.

Hodi FS, Friedlander P, Corless CL, Heinrich MC, Mac Rae S, Kruse A, Jagannathan J, Van den Abbeele AD, Velazquez EF, Demetri GD, Fisher DE. Hodi FS, et al. Among authors: fisher de. J Clin Oncol. 2008 Apr 20;26(12):2046-51. doi: 10.1200/JCO.2007.14.0707. J Clin Oncol. 2008. PMID: 18421059 No abstract available.

6

Adoptive transfer of antigen-specific CD4+ T cells in the treatment of metastatic melanoma.

Hodi FS, Fisher DE. Hodi FS, et al. Among authors: fisher de. Nat Clin Pract Oncol. 2008 Dec;5(12):696-7. doi: 10.1038/ncponc1259. Epub 2008 Oct 14. Nat Clin Pract Oncol. 2008. PMID: 18852719

7

Imatinib targeting of KIT-mutant oncoprotein in melanoma.

Jiang X, Zhou J, Yuen NK, Corless CL, Heinrich MC, Fletcher JA, Demetri GD, Widlund HR, Fisher DE, Hodi FS. Jiang X, et al. Among authors: fisher de. Clin Cancer Res. 2008 Dec 1;14(23):7726-32. doi: 10.1158/1078-0432.CCR-08-1144. Clin Cancer Res. 2008. PMID: 19047099

8

Melanoma from bench to bedside: meeting report from the 6th international melanoma congress.

Fisher DE, Barnhill R, Hodi FS, Herlyn M, Merlino G, Medrano E, Bastian B, Landi MT, Sosman J. Fisher DE, et al. Pigment Cell Melanoma Res. 2010 Feb;23(1):14-26. doi: 10.1111/j.1755-148X.2009.00655.x. Epub 2009 Dec 17. Pigment Cell Melanoma Res. 2010. PMID: 20025711 No abstract available.

9

Identification of the receptor tyrosine kinase c-Met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcoma.

Davis IJ, McFadden AW, Zhang Y, Coxon A, Burgess TL, Wagner AJ, Fisher DE. Davis IJ, et al. Among authors: fisher de. Cancer Res. 2010 Jan 15;70(2):639-45. doi: 10.1158/0008-5472.CAN-09-1121. Epub 2010 Jan 12. Cancer Res. 2010. PMID: 20068147 Free PMC article.

10

New strategies in metastatic melanoma: oncogene-defined taxonomy leads to therapeutic advances.

Flaherty KT, Fisher DE. Flaherty KT, et al. Among authors: fisher de. Clin Cancer Res. 2011 Aug 1;17(15):4922-8. doi: 10.1158/1078-0432.CCR-10-2612. Epub 2011 Jun 13. Clin Cancer Res. 2011. PMID: 21670085 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

388 results

Search Page